Urine titin as a novel biomarker for Duchenne muscular dystrophy

被引：0
|
作者：
Ishii, M. [1 ]
Nakashima, M. [1 ]
Kamiguchi, H. [1 ]
Zach, N. [2 ]
Kuboki, R. [1 ]
Baba, R. [1 ]
Hirakawa, T. [1 ]
Suzuki, K. [1 ]
Quinton, M. [2 ]
机构：
[1] Takeda Pharmaceut Co, Fujisawa, Kanagawa, Japan
[2] Takeda Pharmaceut Co, Boston, MA USA
来源：
NEUROMUSCULAR DISORDERS | 2022年 / 32卷
关键词：
D O I：
10.1016/j.nmd.2022.07.104
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P.56
引用
收藏
页码：S66 / S66
页数：1
相关论文
共 50 条
  • [1] Urine titin as a novel biomarker for Duchenne muscular dystrophy
    Ishii, Misawa Niki
    Nakashima, Masato
    Kamiguchi, Hidenori
    Zach, Neta
    Kuboki, Ryosuke
    Baba, Rina
    Hirakawa, Takeshi
    Suzuki, Kazunori
    Quinton, Maria
    [J]. NEUROMUSCULAR DISORDERS, 2023, 33 (04) : 302 - 308
  • [2] Diagnostic and clinical significance of the titin fragment in urine of Duchenne muscular dystrophy patients
    Awano, Hiroyuki
    Matsumoto, Masaaki
    Nagai, Masashi
    Shirakawa, Taku
    Maruyama, Nobuhiro
    Iijima, Kazumoto
    Nabeshima, Yo-ichi
    Matsuo, Masafumi
    [J]. CLINICA CHIMICA ACTA, 2018, 476 : 111 - 116
  • [3] Proteomics profiling of urine reveals specific titin fragments as biomarkers of Duchenne muscular dystrophy
    Rouillon, Jeremy
    Zocevic, Aleksandar
    Leger, Thibaut
    Garcia, Camille
    Camadro, Jean-Michel
    Udd, Bjarne
    Wong, Brenda
    Servais, Laurent
    Voit, Thomas
    Svinartchouk, Fedor
    [J]. NEUROMUSCULAR DISORDERS, 2014, 24 (07) : 563 - 573
  • [4] Chronodisruption as a biomarker in Duchenne muscular dystrophy
    Alexander, M.
    Monreal-Gutierrez, M.
    Reid, A.
    English, K.
    Wolff, C.
    Lopez, M.
    Siegel, B.
    Phan, H.
    Gamble, K.
    Esser, K.
    [J]. NEUROMUSCULAR DISORDERS, 2023, 33 : S149 - S149
  • [5] Urinary titin reveals persistent proteolysis in Duchenne muscular dystrophy
    Awano, H.
    Matsumoto, M.
    Nagai, M.
    Shirakawa, T.
    Maruyama, N.
    Iijima, K.
    Nabeshima, Y.
    Matsuo, M.
    [J]. NEUROMUSCULAR DISORDERS, 2017, 27 : S168 - S168
  • [6] Can urinary titin be used for predicting Duchenne muscular dystrophy?
    Bai, Shu-Mei
    Guo, Xu-Xiao
    [J]. CLINICA CHIMICA ACTA, 2019, 490 : 161 - 161
  • [7] Can urinary titin be used for predicting Duchenne muscular dystrophy?
    Matsuo, Masafumi
    Awano, Hiroyuki
    Nishio, Hisahide
    [J]. CLINICA CHIMICA ACTA, 2019, 490 : 162 - 162
  • [8] Serum Osteopontin as a Novel Biomarker for Muscle Regeneration in Duchenne Muscular Dystrophy
    Kuraoka, Mutsuki
    Kimura, En
    Nagata, Tetsuya
    Okada, Takashi
    Aoki, Yoshitsugu
    Tachimori, Hisateru
    Yonemoto, Naohiro
    Imamura, Michihiro
    Takeda, Shin'ichi
    [J]. AMERICAN JOURNAL OF PATHOLOGY, 2016, 186 (05): : 1302 - 1312
  • [9] Urinary titin as a biomarker in Fukuyama congenital muscular dystrophy
    Sato, Takatoshi
    Awano, Hiroyuki
    Ishiguro, Kumiko
    Shichiji, Minobu
    Murakami, Terumi
    Shirakawa, Taku
    Matsuo, Masafumi
    Nagata, Satoru
    Ishigaki, Keiko
    [J]. NEUROMUSCULAR DISORDERS, 2021, 31 (03) : 194 - 197
  • [10] Fibronectin is a serum biomarker for Duchenne muscular dystrophy
    Martin, F. Cynthia
    Hiller, Monika
    Spitali, Pietro
    Oonk, Stijn
    Dalebout, Hans
    Palmblad, Magnus
    Chaouch, Amina
    Guglieri, Michela
    Straub, Volker
    Lochmueller, Hanns
    Niks, Erik H.
    Verschuuren, Jan J. G. M.
    Aartsma-Rus, Annemieke
    Deelder, Andre M.
    van der Burgt, Yuri E. M.
    't Hoen, Peter A. C.
    [J]. PROTEOMICS CLINICAL APPLICATIONS, 2014, 8 (3-4) : 269 - 278
12345